Convivia by Bennu / Raptor Pharmaceuticals Corp. (Page 3 of 4)

Adz888 wrote:
Its a long wait guys.
Hey Terry,
Thanks for taking time out in your work to respond, it is greatly appreciated. Last question, purely on your guesswork only, when do you think a product would be developed around?
Regards
Adam

Dear Adam,
Based on our development plan, this product will available in Asian market during 2015.
All the best
Terry
Pharmacist of Regulatory affairs
Uni Pharma Co., Ltd.
:(

Thanks Tobi, better than never. Really looking forward to it though! hopefully, this one will work.

PLEASE! I'm dying for a solution to this problem. Does anyone have any news about convivia?? :)

Hi djelaj12!

What does this mean? Will they be releasing the drug this year?

@Dalmore,

Ok that makes sense... hopefully this product will be available this year, and soon!!
Do you happen to know about the status of the drug in the US?

I have no idea.  I can imagine black market taking advantage of this though.

Will do...please let us know if any of you guys hear anything about Convivia being available in Taiwan and I'll make the trip.

Goodluck trying to find an email, I have searched far and wide

Copy pasted from a website reviewing raptor pharmaceuticals while researching a bit... Makes me very discouraged about convivia :(

"Convivia is taking a drug that is already on the market for specific types of alcohol poisoning and using it as a treatment for Asian Flush.  The drug, 4-methylpyrazole, does work: it is already on the market as a treatment for antifreeze and/or methanol poisoning.  It blocks the enzyme responsible for converting the alcohol to the aldehyde, so the result is that prevents the ethanol from being broken down.  The reduces the build-up of acetaldehyde, a by-product of ethanol processing, which is what causes Asian Flush.  However, the flip-side effect is that it keeps ethanol floating around in the subjects’ bodies for an extended period of time, which effectively causes people to be more drunk—the impact depending on the dosage of 4-methylpyrazole.  The better it works, the longer the patient’s exposure to the side effects of extended ethanol presence in their system, and the more intoxicated the patient would become.

We believe that, as a result of this particular side-effect as well as the fact it’s a gimmicky drug designed purely for treating the results of a vice known to carry negative side effects, the drug will never be approved.  This is likely why RPTP decided not to continue past Stage 2a trials with 32 clients, and instead decided to focus on out-licensing the drug.  In the past several years, RPTP has only succeeded in licensing it out to one company, Uni Pharma, in 2010, and Uni Pharma appears to have abandoned it.  The Uni Pharma website (www.uni-pharma.com) lists its pharmaceutical partners, and RPTP is conspicuously absent.  Likewise, Convivia is conspicuously absent from Uni Pharma’s list of products.  Since announcing the licensing deal with Uni Pharma in June 2010 covering Taiwan with the option of South Korea as well, there have been no further press releases from either company concerning the drug.

Whoever this user was got a reply from someone from Unipharma, so I wouldn't give up hope just yet.

Dear Adam,
Based on our development plan, this product will available in Asian market during 2015.
All the best
Terry
Pharmacist of Regulatory affairs
Uni Pharma Co., Ltd.
:(

"Dear Stephanie:

Unfortunately we have no definite time frame.  The registration takes a long time, and we have no access to the authority reviewing process.

Hope to have your understanding.

Best regards,
Kelin"